Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery
NCT ID: NCT04926597
Last Updated: 2024-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1200 participants
INTERVENTIONAL
2021-08-05
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combining Nutrition Supplementation With an Exercise Program in Elderly Malnourished Frail Patients After Hospital Stay
NCT05325697
Exercise and Nutritional Intervention for Deconditioned Older Adults
NCT01115530
Effect of Oral Nutritional Supplements to Older Patients Discharged With a Rehabilitation Plan
NCT05556876
Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program
NCT03417531
Ability to Meet Enteral Nutritional Needs with a Peptide-based, High Protein Formula
NCT05025267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Yet, the nutritional intervention was not continued after hospital discharge of patients and long-term follow-up data of patients showed a lack of sustained effect of the initial nutritional support strategy. There is a current lack of trial data investigating whether long-term use of nutritional support has a sustained effect on clinical outcomes in this patient population. This study is to compare the continuous use of nutritional support with the use of approved oral nutritional supplements to reach protein and energy goals and to analyze whether medical patients at nutritional risk show a sustained benefit from long-term nutritional support after hospital discharge, and why and how nutritional support affects the course of disease from a mechanistic physio-pathological standpoint.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group: individualized nutritional support
Intervention group patients will receive individualized nutritional support to reach energy and protein goals with the support of an experienced, unblinded dietician and with use of oral nutritional supplements (ONS) as needed
nutritional supplement
daily use of one or more specific oral nutritional supplement with high energy/protein content (i.e., Resource Ultra, Resource 2.0 (Fibre), Resource Ultra Fruit).
individualized nutritional guidelines
nutritional plan supervised by an experienced study dietician based on the usual home nutrition with possibility to increase intake by adaptation to patient preferences, between meal snaking and food enrichment/fortification. Every 2-4 weeks phone call by unblinded study dietician to follow nutritional intervention.
Control group: general information on healthy food habits
Control group patients will receive nutritional counselling (general information on healthy food habits) at discharge, but no nutritional support strategy will be used during follow-up
general nutritional information
general information about health food behavior upon hospital discharge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nutritional supplement
daily use of one or more specific oral nutritional supplement with high energy/protein content (i.e., Resource Ultra, Resource 2.0 (Fibre), Resource Ultra Fruit).
individualized nutritional guidelines
nutritional plan supervised by an experienced study dietician based on the usual home nutrition with possibility to increase intake by adaptation to patient preferences, between meal snaking and food enrichment/fortification. Every 2-4 weeks phone call by unblinded study dietician to follow nutritional intervention.
general nutritional information
general information about health food behavior upon hospital discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult (age ≥18 years), medical patients
* Nutritional risk screening using the Nutritional Risk Screening (NRS): total score ≥3 points consisting of ≥1 points for impairment of the nutritional status \[weight loss \>5% in 3 month or food intake of 50-75% in the last week before hospital admission\] plus ≥1 for the severity of the disease (i.e., cancer, chronic kidney disease, chronic heart failure, COPD) and other chronic diseases according to the definition of the "National Center for Chronic Disease Prevention and Health Promotion": Chronic diseases are defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both .
Exclusion Criteria
* unable to ingest oral nutrition
* need for long-term nutrition,
* terminal condition
* acute pancreatitis or acute liver failure
* patients discharged to a nursing home
* patients unlikely to comply with nutritional support treatment (e.g., dementia)
* COVID-Hospitalisation requiring intensive care
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philipp Schuetz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Philipp Schuetz
Prof. Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philipp Schuetz, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Kantonsspital Aarau, University Department of Internal Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitari Vall Hebron de Barcelona
Barcelona, , Spain
Hospital Universitario de Getafe
Getafe, , Spain
Complejo AComplejo Asistencial Universitario de León
León, , Spain
Hospital U. Gregorio Marañón de Madrid
Madrid, , Spain
Hospital Universitario Regional de Málaga
Málaga, , Spain
Hospital Clínico Universitario de Valladolid
Valladolid, , Spain
Spital Zofingen
Zofingen, Canton of Aargau, Switzerland
Spital Emmental Burgdorf
Burgdorf, Canton of Bern, Switzerland
Spital Thun
Thun, Canton of Bern, Switzerland
Spital Lachen
Lachen, Canton of Schwyz, Switzerland
Kantonsspital Münsterlingen
Münsterlingen, Thurgau, Switzerland
Kantonsspital Aarau, University Department of Internal Medicine
Aarau, , Switzerland
Bern University Hospital, Department of General Internal Medicine
Bern, , Switzerland
Kantonsspital Lucerne, Department of Internal Medicine
Lucerne, , Switzerland
Kantonsspital Sankt Gallen
Sankt Gallen, , Switzerland
Klinik Hirslanden Zürich
Zurich, , Switzerland
Stadtspital Zürich
Zurich, , Switzerland
Universitätsspital Zürich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Vojtech Pavlicek, Dr. med.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-00278; ex20Schuetz
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.